BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15540759)

  • 1. Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.
    Kloner RA; Jackson G; Emmick JT; Mitchell MI; Bedding A; Warner MR; Pereira A
    J Urol; 2004 Nov; 172(5 Pt 1):1935-40. PubMed ID: 15540759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
    Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI
    J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects.
    Giuliano F; Kaplan SA; Cabanis MJ; Astruc B
    Urology; 2006 Jun; 67(6):1199-204. PubMed ID: 16765179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA
    Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of tadalafil.
    Kloner RA; Mitchell M; Emmick JT
    Am J Cardiol; 2003 Nov; 92(9A):37M-46M. PubMed ID: 14609622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
    Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
    Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.
    Gu N; Kim J; Lim KS; Shin KH; Kim TE; Lee B; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Sep; 34(9):1929-39. PubMed ID: 22921287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin.
    Kim MG; Kim JR; Kim BH; Lim KS; Shin SG; Jang IJ; Yu KS; Cho JY
    Curr Med Res Opin; 2013 Jun; 29(6):685-93. PubMed ID: 23557068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of tamsulosin and sildenafil in separate and combined regimens on detailed hemodynamics in patients with benign prostatic enlargement.
    Nieminen T; Tammela TL; Kööbi T; Kähönen M
    J Urol; 2006 Dec; 176(6 Pt 1):2551-6. PubMed ID: 17085157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
    J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Ng CF; Wong A; Cheng CW; Chan ES; Wong HM; Hou SM
    J Urol; 2008 Sep; 180(3):1042-6. PubMed ID: 18639296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial.
    Goldfischer E; Kowalczyk JJ; Clark WR; Brady E; Shane MA; Dgetluck N; Klise SR
    Urology; 2012 Apr; 79(4):875-82. PubMed ID: 22341603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antagonistic activity of tamsulosin and doxazosin at vascular alpha 1-adrenoceptors in humans.
    Harada K; Ohmori M; Fujimura A
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):557-61. PubMed ID: 8938652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.
    Bechara A; Romano S; Casabé A; Haime S; Dedola P; Hernández C; Rey H
    J Sex Med; 2008 Sep; 5(9):2170-8. PubMed ID: 18638006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study.
    Oelke M; Giuliano F; Baygani SK; Melby T; Sontag A
    BJU Int; 2014 Oct; 114(4):568-75. PubMed ID: 24612148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of pharmacodynamic interaction of silodosin, a highly selective alpha1a-adrenoceptor antagonist, with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men.
    MacDiarmid SA; Hill LA; Volinn W; Hoel G
    Urology; 2010 Mar; 75(3):520-5. PubMed ID: 20080287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial.
    Regadas RP; Reges R; Cerqueira JB; Sucupira DG; Josino IR; Nogueira EA; Jamacaru FV; de Moraes MO; Silva LF
    Int Urol Nephrol; 2013 Feb; 45(1):39-43. PubMed ID: 23108604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
    Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
    J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.